Coverage
-
October 06, 2014
The U.S. Supreme Court declined Monday to review the Fourth Circuit's dismissal of a former worker's whistleblower complaint accusing Omnicare Inc. of defrauding Medicare by selling contaminated drugs, preserving a sweeping decision that may sharply limit False Claims Act suits over quality control lapses.
1 other articles on this case.
View all »